GSK plc reported the purchase of 470,000 ordinary shares at prices between 2,217p and 2,264p on 19 February 2026, as part of a buyback program, bringing total purchases since 17 February 2026 to 1,300,000 shares. The company now holds 241,191,094 shares in treasury out of 4,074,951,475 issued shares.